Product Information
TAZAROTENE 0.1% CREAM is a generic product labeled by Mayne Pharma, priced at $1.9245 per GM under NDC 68308074530. Its NADAC has been published 240 times since Mar 2, 2022.
FDA first approved this application on Dec 22, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
1 mg/g
Manufacturer
Mayne PharmaNDC
68308074530
Classification
Generic
Dosage Form
CREAM
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
TAZAROTENEApproval Type
Generic (ANDA)
FDA Application
ANDA208662FDA Approved
12/22/2017
TE Code
AB
On Market Since
11/10/2021
Pharmacological Classes
Price Statistics
The NADAC for TAZAROTENE 0.1% CREAM has been published 240 times since Mar 2, 2022, and over the history we have for it it has declined 52.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.9245 per GM |
|---|---|
| All-time high | $4.0220 (Mar 16, 2022) |
| All-time low | $1.4726 (Jul 17, 2024) |
| 52-week high | $2.3074 |
| 52-week low | $1.8023 |
| Median price | $2.1793 |
| Average price | $2.2940 |
| Largest weekly change | +46.8% (Mar 22, 2023) |
| Weeks tracked | 240 |
| Tracking since | Mar 2, 2022 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the TAZAROTENE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Mayne Pharma manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
TAZAROTENE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Retinoid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TAZAROTENE 0.1% CREAM?
The current National Average Drug Acquisition Cost (NADAC) for TAZAROTENE 0.1% CREAM, manufactured by Mayne Pharma, is $1.9245 per GM (NDC 68308074530), effective Sep 30, 2026.
How has the price of TAZAROTENE 0.1% CREAM changed over time?
Over the history we have for it, the NADAC for TAZAROTENE 0.1% CREAM has declined 52.2%. It has been tracked across 240 weekly CMS publications since Mar 2, 2022.
What are the highest and lowest recorded NADAC prices for TAZAROTENE 0.1% CREAM?
Since Mar 2, 2022, the NADAC for TAZAROTENE 0.1% CREAM has ranged from a low of $1.4726 (Jul 17, 2024) to a high of $4.0220 (Mar 16, 2022), with a median of $2.1793 per GM.
Are there cheaper alternatives to TAZAROTENE 0.1% CREAM?
No other NADAC-published product currently shares the active ingredient and strength of TAZAROTENE 0.1% CREAM in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures TAZAROTENE 0.1% CREAM?
TAZAROTENE 0.1% CREAM (NDC 68308074530) is labeled by Mayne Pharma, and CMS classifies it as a generic product.